Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
09/2001
09/05/2001EP1129089A1 Spiro-indolines as y5 receptor antagonists
09/05/2001CN1070368C Method for prepn. of pharmaceutical composition contg. imidazo [2,1-6] [3] benzoazepine derivatives
09/04/2001US6284753 Grampositve bacteria
08/2001
08/30/2001US20010018515 Photonic or electronic energy conducting
08/28/2001US6281354 Analogs of duocarmycin and cc-1065
08/28/2001US6281198 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro-[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one compounds
08/28/2001CA2015996C Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
08/23/2001US20010015614 Novel indolizine compound, production process for novel indolizine compound, organic light-emitting device material having indolizine skeleton, and organic light-emitting device using these
08/22/2001EP1125938A1 Protein kinase inhibitors for treatment of neurological disorders
08/22/2001EP1124822A1 Thrombin inhibitors
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/22/2001EP0949262B1 Cephem compounds
08/21/2001US6277986 Photoactivatable nitrogen-containing bases based on α-amino ketones
08/21/2001US6277843 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
08/16/2001WO2001058900A1 1h-imidazopyridine derivatives
08/16/2001WO2001058898A1 Preventive or therapeutic agents for gastric or esophageal regurgitation
08/16/2001WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
08/16/2001EP0828715B1 N-oxides as antibacterial agents
08/16/2001CA2399136A1 1h-imidazopyridine derivatives
08/14/2001US6274757 Neuromuscular relaxants
08/14/2001US6274623 Neuromuscular relaxants
08/14/2001CA2159640C Second messenger cell signaling inhibitors
08/09/2001WO2001014376A8 Novel spiro compounds
08/07/2001US6271222 Antibiotic
08/02/2001WO2001055719A2 Diagnostic kit for detecting creatine levels
08/02/2001WO2001055155A1 Novel carbapenem derivatives of quaternary salt type
08/02/2001WO2001055154A1 Novel carbapenem derivatives
08/02/2001US20010011086 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
08/02/2001CA2398481A1 Novel carbapenem derivatives
08/02/2001CA2398478A1 Novel quaternary salt-type carbapenem derivatives
08/01/2001EP1119571A2 Tricyclic delta3-piperidines as alpha2-antagonists
07/2001
07/31/2001US6268378 Integrin receptor antagonists
07/26/2001WO2001053305A1 Processes for the preparation of carbapenem derivatives
07/26/2001WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents
07/26/2001US20010009914 Acridone-derived compounds useful as antineoplastic and antiretroviral agents
07/25/2001EP1118616A1 Process for the production of 5'-nor-anhydrovinblastine ditartrate from plants of genus catharanthus
07/25/2001EP1117667A1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS
07/25/2001CN1305480A Pyrolo [2,3-d] pyrimidine compounds
07/25/2001CN1305479A Pyrrolo [2,3-d] pyrmidine compounds
07/24/2001US6265395 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
07/18/2001CN1304309A Semi-synthetic ecteinascidins
07/17/2001US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents
07/12/2001WO2001049682A1 Condensed azepines as vasopressin agonists
07/11/2001EP1113796A1 FUSED PYRIDINE INHIBITORS OF cGMP PHOSPHODIESTERASE
07/11/2001EP1019042A4 Anti-first-pass effect compounds
07/10/2001US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases
07/10/2001US6258319 Device and method for photoactivation
07/05/2001WO2001047922A2 Azaindoles
07/05/2001WO2001009094A3 Chemokine receptor antagonists and methods of use therefor
07/05/2001CA2699568A1 Azaindoles
07/04/2001EP0579615B1 New bi- and tricyclic aminoalcohol esters, their preparation and their use in medicaments
06/2001
06/28/2001WO2001046200A1 Novel piperidine and piperazine derivatives
06/28/2001WO2000077010A3 Substituted heterocycle fused gamma-carbolines
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001CA2394095A1 Novel piperidine and piperazine derivatives
06/27/2001EP1109815A1 Chemokine receptor antagonists and methods of use therefor
06/27/2001EP1109812A2 Pyrrolobenzodiazepines
06/27/2001EP1109811A2 Pyrrolobenzodiazepines
06/27/2001EP0862564A4 Photoactivatable compounds for the prevention of intimal hyperplasia and other diseases
06/26/2001US6252063 Salt forming using alkali metal compound
06/26/2001US6251891 Carbapenem derivatives
06/26/2001US6251890 Treating or preventing bacterial infections in mammalian patients
06/26/2001CA1341262C A new process of the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine
06/26/2001CA1341261C Process for the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine
06/21/2001WO2001044250A1 SUBSTITUTED 1,2,3-TRIAZOLO[1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
06/21/2001WO2001044235A2 Agents and methods for the treatment of proliferative diseases
06/21/2001CA2392955A1 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
06/20/2001EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
06/20/2001CN1067395C Process for preparing diketopyrrolpyrrde derivatives
06/19/2001US6248776 Anti-first-pass effect compounds
06/14/2001WO2001042505A2 Fluorescent quenching detection reagents and methods
06/14/2001WO2001042243A2 Protein kinase inhibitors
06/14/2001CA2396795A1 Fluorescent quenching detection reagents and methods
06/12/2001US6245449 Material for organoelectroluminescence device and use thereof
06/07/2001WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors
06/07/2001WO2001039742A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/06/2001EP1104424A1 Process for the synthesis of carbapenem intermediates, and compounds produced
06/05/2001US6242437 Cephem derivatives
05/2001
05/31/2001WO2001038331A2 Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition
05/31/2001WO1999064041A9 Multibinding agents that modulate nmda receptors
05/31/2001CA2391103A1 Pyrazolo¬1,5-d|¬1,2,4|triazines for enhancing cognition
05/30/2001EP1102768A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
05/30/2001EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors
05/30/2001CN1297450A Preparation of alkylthio- and/or arylthio-substd. diketo-diaryl-pyrrolopyrroles
05/29/2001US6239132 Thrombin inhibitors
05/29/2001US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones
05/29/2001CA2172616C Tropyl 7-azaindol-3-ylcarboxyamides as antitussive agent
05/29/2001CA2091506C Thieno[3,2-b]pyridine derivatives
05/23/2001EP1101766A1 Novel carbapenem derivatives
05/23/2001EP1100519A1 Multibinding agents that modulate nmda receptors
05/23/2001CN1296008A Dioxacyclopentedien-6-(5aH)-one compound, its preparation process and medicinal composition
05/23/2001CN1066148C Tricyclic benzazepine compounds
05/17/2001WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists
05/17/2001WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same
05/17/2001WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds
05/17/2001DE19953454A1 Neue Thiophene und Verfahren zu ihrer Polymerisation New thiophenes and their methods of polymerization
05/17/2001CA2390496A1 Polycycloalkylpurines as adenosine receptor antagonists
05/17/2001CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds
05/16/2001EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 111